Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma.
Clin Transl Oncol
; 22(6): 900-907, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-31555967
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Mitogen-Activated Protein Kinase Kinases
/
Proto-Oncogene Proteins B-raf
/
Protein Kinase Inhibitors
/
Melanoma
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Clin Transl Oncol
Year:
2020
Type:
Article
Affiliation country:
Italy